Final answer:
The term for discussing study details with participants after a double-blind study is known as debriefing. It is part of the informed consent process and ensures participants are fully aware of all aspects of the study.
Step-by-step explanation:
After conducting a study where neither the researchers nor the participants know who is receiving the treatment or the placebo, a practice known as a double-blind procedure, the meeting with participants to discuss relevant details and information about the research is termed debriefing.
This is an essential part of ethical research, falling under the realm of informed consent, where researchers ensure that participants are aware of the study's nature, procedures, results, and any risks or benefits involved. Debriefing also allows the researchers to reveal which participants were in the control group or the treatment group, and to provide additional information that was not available to participants during the study to prevent bias.